D-0010-2027 Class II Ongoing

Recalled by Ajanta Pharma USA Inc — Bridgewater, NJ

FDA drug recall D-0010-2027 was initiated by Ajanta Pharma USA Inc on Sep 17, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications: below specification The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Oct 7, 2026
Initiation Date
Sep 17, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

Reason for recall

Failed Dissolution Specifications: below specification

Distribution pattern

Nationwide in the US.

Code information

Lot: DJ25134, Exp 11/30/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0010-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0010-2027. Report a data issue: hello@regdatalab.com.